Related Experiment Videos
[Detection methods for drug-resistant bacteria in routine examination--VISA].
1Clinical Laboratory, Kobe University Hospital.
Rinsho Byori. the Japanese Journal of Clinical Pathology
|May 11, 2000
Summary
Vancomycin-intermediate Staphylococcus aureus (VISA) and hetero-vancomycin-resistant MRSA (hetero-VRSA) exhibit low-level vancomycin resistance. Standard disk diffusion tests fail to detect these strains, necessitating specialized methods like population analysis for accurate identification.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Context:
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant public health threat.
- Emergence of vancomycin resistance in MRSA strains complicates treatment options.
- Vancomycin-intermediate Staphylococcus aureus (VISA) and hetero-VRSA represent challenging resistance phenotypes.
Purpose:
- To characterize vancomycin resistance mechanisms in MRSA.
- To evaluate diagnostic methods for detecting VISA and hetero-VRSA.
- To identify reliable techniques for identifying low-level vancomycin resistance in MRSA.
Summary:
- VISA strains display vancomycin Minimum Inhibitory Concentrations (MICs) of 8-16 µg/mL.
- Hetero-VRSA strains possess subpopulations resistant to vancomycin MICs of 1-4 µg/mL.
- These resistant strains lack common vancomycin resistance genes (vanA, vanB, vanC) found in VRE.
Impact:
- Standard disk diffusion tests are inadequate for detecting VISA and hetero-VRSA.
- MIC testing can confirm VRSA but may miss hetero-VRSA.
- Population analysis and specialized agar (MU3) are crucial for detecting hetero-VRSA, improving clinical management of MRSA infections.